Pharmalink Consulting appoints five consultants
February 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmalink Consulting
Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, …
Abbott seeks leukemia test
February 25, 2013Sales and Marketing AbbVie, Abbott, Janssen
Abbott is to team up with Janssen Biotech and biopharma firm Pharmacyclics to seek a diagnostic test for leukemia patients. …
FDA approves Kadcyla
February 25, 2013Herceptin, Roche, T-DM1
Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …
$33m prizes for research
February 22, 2013Research and Development Breakthrough Prize in Life Sciences, Cancer, Facebook, google
Life science research has a new multi-million dollar prize from the founders of Facebook and Google.The not-for-profit Breakthrough Prize in …
Ariad expands in Europe
February 22, 2013Sales and Marketing Ariad, leukaemia, leukemia
The new European boss of Ariad Pharmaceuticals has sketched out the US firm’s plans for its next-generation leukaemia drug, which …
Roche censured for drunken conference antics
February 21, 2013Medical Communications, Sales and Marketing ABPI, PMCPA, Roche
The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …
Watson: the supercomputer revolution begins here
February 21, 2013Medical Communications Watson, ibm
Watson, a supercomputer developed by IBM is to make its debut helping oncologists diagnose and choose the best treatment for …
John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?
February 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency
You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …
Pharma losing in ‘valley of death’
February 21, 2013Research and Development, Sales and Marketing Bath, Evotec, pharma
An academic from Bath University has warned that much of pharma’s most promising research is being lost before it can …
Lundbeck elects new chairman
February 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck
Lundbeck has announced it will be electing Håkan Björklund as its new chairman as Mats Pettersson steps down. Pettersson, a …
SHL to invest 40 Million USD in 2013 to significantly expand production facilities
February 21, 2013Manufacturing and Production auto injectors, autoinjector, drug delivery, pen injectors
SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices …
NHS Confederation appoints two directors
February 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, confederation
The NHS Confederation has announced the appointment of two new directors to the organisation. Dr Johnny Marshall (pictured) and Matt …
FDA accepts GSK’s Anoro
February 20, 2013Research and Development, Sales and Marketing FDA, GSK, Theravance, anoro
The FDA has accepted a New Drug Application for GlaxoSmithKline and biopharma firm Theravance’s investigational COPD drug UMEC/VI. A decision …
Phytopharm suffers Parkinson’s loss
February 20, 2013Research and Development, Sales and Marketing Parkinson's, Phytopharm, cogane
Phytopharm is facing an uncertain future after the failure of one of its most promising drugs in a Phase II …
Strategic North launches thought leaders book
February 20, 2013Medical Communications Strategic North, health policy
A healthcare consultancy has launched a book collecting thoughts and insights from experts in health and beyond.Strategic North, a strategic …
Director-level role hire at Insight Research Group
February 20, 2013Medical Communications, Research and Development, Sales and Marketing Insight Research Group, carolyn dodd
Carolyn Dodd has taken up a director-level position at healthcare consultancy firm Insight Research Group. Dodd previously spent 12 years …
VBP negotiations ‘opened up’
February 19, 2013Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP
Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …
Vasella forgoes golden handshake after furore
February 19, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Vasella
Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …
GSK plans greater use of biocatalysis, continuous processing
February 19, 2013Manufacturing and Production GSK, Witty, biocatalysis
GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …
inVentiv Health names new European head
February 19, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health
Michel Dubery has been named as the new managing director of inVentiv Health Communications in Europe. Dubery brings more than …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
